Completed NA INTERVENTIONAL 2-arm NCT03487146

HP Improves Sleep and Overall Survival Rate in Maintenance Hemodialysis Patients

Hemoperfusion in Combination With Hemodialysis for Improvement of Self-reported Sleep Disturbance and Overall Survival Rate in Maintenance Hemodialysis Patients

Sponsor: Shanghai Pudong Hospital

Conditions Hemoperfusion

Interventions hemoperfusion(HP)

Updated 5 times since 2018 Last updated: Apr 3, 2018 Started: May 1, 2015 Primary completion: Aug 1, 2017 Completion: Dec 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hemoperfusion and is currently completed. Shanghai Pudong Hospital leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2018 — Jun 2018 [monthly]

Completed NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Pudong Hospital

Data source: Shanghai Pudong Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.